Researchers from Stanford University and the Chan Zuckerberg Biohub developed a novel AI-based ‘Virtual Lab,’ where multiple specialized AI agents collaborate, simulating multidisciplinary scientific teams to tackle complex biological problems. Leveraging large language models and domain expertise, the system autonomously formulates hypotheses, conducts virtual experiments, and critically analyzes outcomes, expediting research cycles. Demonstrated through rapid design of SARS-CoV-2 nanobodies, the platform promises to democratize and accelerate discovery in biomedical sciences, particularly benefiting resource-limited groups lacking access to diverse expertise.